Identifies protein signatures in plasma for diagnosing Parkinson's disease and multiple system atrophy, suggesting unique disease pathways.
To identify plasma protein signatures distinguishing Parkinson’s disease (PD) and multiple system atrophy (MSA), and to evaluate their associations with disease severity and diagnostic potential.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: